Tower Research Capital LLC (Trc) Logic Bio Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.29 - $0.67 $2,995 - $6,919	-10,328 Reduced 46.74%	11,768 $3,000
Q2 2022 Aug 15, 2022	BUY	$0.35 - $0.74 $3,337 - $7,055	9,535 Added 75.91%	22,096 $8,000
Q1 2022 May 12, 2022	BUY	$0.61 - $2.49 $5,823 - $23,772	9,547 Added 316.76%	12,561 $8,000
Q4 2021 Feb 14, 2022	BUY	$2.2 - $4.53 $4,111 - $8,466	1,869 Added 163.23%	3,014 $7,000
Q3 2021 Nov 15, 2021	SELL	$3.85 - $5.09 $9,490 - $12,546	-2,465 Reduced 68.28%	1,145 $5,000
Q2 2021 Aug 16, 2021	BUY	$4.03 - $7.57 $1,882 - $3,535	467 Added 14.86%	3,610 $16,000
Q1 2021 May 17, 2021	BUY	$6.8 - $9.16 $8,207 - $11,056	1,207 Added 62.35%	3,143 $23,000
Q4 2020 Feb 16, 2021	SELL	$5.29 - $9.1 $52,778 - $90,790	-9,977 Reduced 83.75%	1,936 $15,000
Q3 2020 Nov 16, 2020	BUY	$5.41 - $9.45 $53,721 - $93,838	9,930 Added 500.76%	11,913 $108,000
Q2 2020 Aug 13, 2020	SELL	$4.25 - $8.46 $1,130 - $2,250	-266 Reduced 11.83%	1,983 $17,000
Q1 2020 May 15, 2020	BUY	$4.06 - $11.0 $9,130 - $24,739	2,249 New	2,249 $11,000
Q3 2019 Nov 05, 2019	SELL	$6.97 - $13.46 $10,615 - $20,499	-1,523 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$9.77 - $17.08 $8,929 - $15,611	914 Added 150.08%	1,523 $20,000
Q1 2019 May 14, 2019	BUY	$7.93 - $10.41 $4,829 - $6,339	609 New	609 $6,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.